BOSSRA
ABBV icon

B.O.S.S. Retirement Advisors’s AbbVie ABBV Stock Holding History

B.O.S.S. Retirement Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$359K Buy
1,427
+43
+3% +$9.25K 0.1% 117
2026
Q1 		$301K Sell
1,384
-84
-6% -$18.6K 0.09% 132
2025
Q4 		$335K Sell
1,468
-323
-18% -$73.6K 0.11% 121
2025
Q3 		$415K Sell
1,791
-192
-10% -$39.1K 0.1% 135
2025
Q2 		$368K Sell
1,983
-97
-5% -$18K 0.09% 135
2025
Q1 		$436K Sell
2,080
-287
-12% -$55.8K 0.13% 110
2024
Q4 		$421K Sell
2,367
-21,638
-90% -$3.98M 0.12% 117
2024
Q3 		$4.74M Buy
24,005
+2,105
+10% +$393K 0.95% 34
2024
Q2 		$3.76M Buy
21,900
+6,839
+45% +$1.13M 0.96% 35
2024
Q1 		$2.33M Sell
15,061
-2,659
-15% -$458K 0.89% 39
2023
Q4 		$2.75M Buy
17,720
+241
+1% +$35.1K 0.53% 50
2023
Q3 		$2.61M Buy
17,479
+1,766
+11% +$259K 0.56% 45
2023
Q2 		$2.12M Buy
15,713
+77
+0.5% +$11.3K 0.45% 65
2023
Q1 		$2.49M Buy
15,636
+1,372
+10% +$210K 0.59% 46
2022
Q4 		$2.31M Buy
+14,264
New +$2.19M 0.59% 50

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

B.O.S.S. Retirement Advisors's ABBV Position: Q2 2026 in Review

B.O.S.S. Retirement Advisors increased its AbbVie (ABBV) stake by 3.1% in Q2 2026, buying an estimated $9.25K and bringing the position to 1,427 shares worth $359K. The position accounts for 0.1% of the portfolio, ranked #117.

B.O.S.S. Retirement Advisors first reported a position in ABBV in Q4 2022 and has held it in 15 quarters since. The position peaked at $4.74M in Q3 2024. 4,193 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • B.O.S.S. Retirement Advisors held 1,427 shares of AbbVie worth $359K as of Q2 2026.
  • B.O.S.S. Retirement Advisors bought 43 AbbVie shares in Q2 2026, an estimated $9.25K.
  • AbbVie made up 0.1% of B.O.S.S. Retirement Advisors's portfolio in Q2 2026, its #117 holding.
  • B.O.S.S. Retirement Advisors first reported a position in AbbVie in Q4 2022 and has held it in 15 quarters since.
  • B.O.S.S. Retirement Advisors's AbbVie position peaked at $4.74M in Q3 2024.
  • 4,193 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on B.O.S.S. Retirement Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.